© 2022 MJH Life Sciences and Nutritional Outlook. All rights reserved.

© 2022 MJH Life Sciences™ and Nutritional Outlook. All rights reserved.

With elderberry’s fortunes rising along with the research, can we expect its good luck to continue?

When a wellness ingredient can claim consistent therapeutic use for close to several millennia, it’s fair to say that 1) it’s no longer an up-and-comer, and 2) it must be doing something right.

Such is certainly the case with elderberry (Sambucus nigra), which was as much of an herbal staple in Ancient Greece as it is in our own COVID-cursed era.

And as it happens, the pace of science both supporting elderberry’s benefits and elucidating its actions has ramped up significantly even over the past few years, with PubMed listing more than 400 published studies on elderberry (or elder berry, as it sometimes appears; more on that later) from the last half-decade alone.

Looking back a full decade to 2012, Holly E. Johnson, PhD, chief science officer, American Herbal Products Association (AHPA; Silver Spring, MD), notes that roughly 50 to 80 elderberry studies have hit publications each year since, “many of which investigate its bioactivity and mechanistic influences on the immune system,” she adds.

So with elderberry’s fortunes rising along with the research, can we expect the good luck to continue? If brands make the most of this powerful botanical, we sure can.

According to the American Botanical Council’s (ABC; Austin, TX) annual HerbalGram Herb Market Report, mass-market elderberry sales grew first from about $51 million in 2018 to nearly $108 million in 2019, and then to almost $276 million in 2020—an almost stratospheric rise that, in light of the pandemic, was clearly no coincidence. And while the ABC hasn’t crunched 2021’s numbers yet, Stefan Gafner, PhD, ABC’s chief science officer, is confident remarking that the past three years’ domestic growth alone “has been quite impressive.”

Nutritional Outlook interviewed Chris Tower when he was vice president of sales and business development at Artemis International (Fort Wayne, IN). (In August, Tower joined Euromed USA Inc. as general manager.) Tower confirmed that demand for Artemis’s ElderCraft elderberry extract “was off the charts” during that same period, he claimed, adding that, “for perspective, we exhausted our two-year safety stock of frozen berries within calendar 2020 and had to implement a carefully managed allocation process to fulfill sales commitments to customers through the first quarter of 2021.”

While a “relative ebb” had finally descended on the frenzy by 2021’s Q2, with summer ’22 now in full swing and families on the move, Tower declared, “ElderCraft sales and new-product launches have significantly surged again. And flu season is still on the horizon.”

You’ve seen it written both ways—so which is correct: elderberry, or elder berry?

“I really like this question,” says Mark Blumenthal, founder and executive director, American Botanical Council (ABC; Austin, TX). “And there’s certainly no shortage of opinions on the issue.”

ABC’s Botanical Adulterants Prevention Program (BAPP) published a review on elderberry adulteration in its journal HerbalGram in 2021, and the discussion therein noted that “sources disagree about the use of the common name elder versus elderberry,” Blumenthal says.

Historically, it appears that elder served as a descriptor for different plant parts—as in elder berry, elder flowers, elder leaves, et al. And while the compound terms elderberry and elderflower do see wider use among industry and the public today, the United States Pharmacopeia (USP) Dietary Supplements & Herbal Medicines (DSHM) Nomenclature Joint Subcommittee actually currently recommends referring to the plant’s fruit as elder berry, Blumenthal says.

“However,” he continues, “industry members appear to prefer the term elderberry, despite this leading to some inconsistencies in the terminology.”

Of course, all of this is in keeping with elderberry’s track record of periodic surges—a track record that traces back ages.

“Elderberries have a long history of medicinal use,” Gafner points out. “Traditionally, the berry was used for a number of issues, mostly in the form of a juice or syrup as a mild laxative, diuretic, and diaphoretic—perspiration-promoting—agent for the common cold.”

As recently as the flu season of 2018-2019, which Melanie Bush, Artemis’s vice president of science and research, describes as “particularly bad,” “mainstream awareness of elderberry had already been rising, dovetailing nicely with its emerging public reputation as a helpful remedy” for such illness outbreaks.

That awareness merely solidified with COVID-19, and for good reason: “These little dark berries are all about immune support,” Bush says. But don’t take her word for it; survey the science.

Bush notes, for example, that a human pilot study1 conducted in the early-2000s concluded that elderberry can reduce influenza-symptom severity and duration, with a subsequent study2 published less than a decade later demonstrating elderberry extract’s direct antiviral and antibacterial action in a lab setting.

Those findings paved the way for a now oft-cited large-scale human clinical trial3 involving long-haul flight passengers confirming elderberry’s ability to reduce symptom severity and duration in upper respiratory tract infections like colds and flu.

And in 2019, a meta-analysis4 evaluating all clinical data generated to date leveled this “clinically relevant verdict,” says Bush: “Supplementation with elderberry extract reduces symptom duration and severity in colds and influenza. There you have it.”

What more could anyone want? Well, mechanistic data wouldn’t hurt, and that’s just what more recent research is delivering.

Consider that some of the main bioactives in European black elderberry are anthocyanin flavonoids, Bush explains, with cyanidin-3-sambubioside predominant among them. Studies now show that cyanidin-3-sambubioside appears to block the binding of influenza viral glycoproteins to host cells, she says, thus blocking virus entry and replication.5

“Additionally,” Bush continues, “polysaccharides from elderberry were identified as having immune-boosting properties6—evidence that was corroborated in a brand-new study in which the polysaccharides in ElderCraft extract exerted direct immune-stimulating properties in dendritic cells and cytokines.”7

Finally, she points to new studies nearing completion and publication that demonstrate ElderCraft’s inhibition of SARS-CoV-2 replication in vitro, as well as its support for a healthy immune system “by way of exerting prebiotic benefits in humans for a healthy gut,” she says.

Tower noted that because elderberry’s anthocyanins are relatively heat-sensitive and can degrade at temperatures above 90°C—conditions frequently encountered in conventional processing methods—Artemis extracts its ingredient using a proprietary water-extraction and ultrafiltration-concentration process called Iprona Polyphenol Technology (IPT).

“The IPT process’s uniqueness in large part retains and concentrates the full embodiment of our whole fresh and frozen Haschberg European black elderberry fruit,” Tower claimed. That leaves the finished ingredient “highly stable” in its dried extract form, he said, as well as highly water-soluble, palatable, and “organoleptically representative of fresh elderberry fruit.”

Those advantages have helped the ingredient chart an “exceptionally robust” course into formulations ranging from gummies and syrups to soft gels, capsules, chewable tablets, RTD beverages, teas, effervescent powders, and more, said Tower. “And on an even more niche level,” he noted, “ElderCraft formulates well into liposomal suspensions and functional chewing gum.”

Again, to ensure that these formulations deliver the potency consumers expect, Bush suggests that brands insist on elderberry extracts standardized to anthocyanin content and “made with gentle processing that retains other important bioactives within the fruit matrix.” But beyond that, she says, brands should also be on high alert for adulteration.

“When an ingredient’s star rises and it becomes popular,” she explains, “there’s always risk of bad actors getting a piece of the action through dishonest practices like adulteration. Unfortunately, elderberry is no exception.” The result, she says: “Misbranding is an issue in the market, as low-grade elderberry ingredients get passed off as more premium extracts.”

Most clinical data pertain to extracts from the plant’s berry, and not to those from other plant parts, for example. But given that the going rate for destemmed elderberries can be as much as times ten times that of berries with the stems attached8, shady suppliers have an incentive to get in on that action even while selling stem-on berries. Thus, Gafner concedes that though he’s seen little indication of flowers, leaves, or other structures winding up in elderberry products, “brands that economize may inadvertently buy product that’s not all berry.”

But the “bigger concern” for Gafner and others is intentional adulteration with extracts from lower-cost plants containing similar anthocyanins—say, black rice. It’s a temptation that pandemic- and now harvest-induced supply shortages have exacerbated9, he says, and recent studies do, in fact, hint that such adulteration of elderberry supplements “appears to be quite common.”10,11

Gafner’s advice is therefore not buying based on price. “And make sure your extract is authentic,” he says. “If you don’t have an in-house laboratory, you should use a reputable contract-analytical laboratory to authenticate the material.”

Tower agreed. “Adulteration of elderberry—particularly extracts—remains so commonplace that ‘buyer beware’ should be the default position,” he wagered. “When sourcing and qualifying elderberry ingredients, it’s essential to work with leading, transparent, trusted suppliers with clear chain-of-custody oversight from harvest through manufacture, and comprehensive shared quality parameters, including species authentication.”

Again, standardization to anthocyanins is key, he said, adding that brands should “pointedly question suppliers offering high-ratio ‘so-called’ extracts at a low cost.”

Bush agrees, and notes that Artemis has worked with accredited labs and organizations like the ABC, with whom it helped produce industry guidance through ABC’s Botanical Adulterants Prevention Program (BAPP). She adds that the United States Pharmacopeia (USP) also hopes to support brands’ efforts to “do their due diligence” with an update to its monograph of standardized methods for quantitatively and qualitatively analyzing elderberry ingredients.

But ultimately, she says, “In today’s business climate, it’s essential to work with trusted suppliers who specialize in European black elderberry. Transparent chain-of-custody documentation, from field to final product, should come standard, as should control over raw-material quality.” Like elderberry’s benefits themselves, such advice is timeless.